Navigation Links
Intelsius Launches Highest Performing Products
Date:5/15/2012

YORK, England, May 15, 2012 /PRNewswire/ -- Intelsius, a DGP company, a designer, manufacturer and distributor of temperature-controlled packaging solutions based in York, announced the launch of its new ORCA™ range of products.  The announcement was made on board the DFDS ship King Seaways in Newcastle today.

(Photo: http://photos.prnewswire.com/prnh/20120509/DE02535
(Logo: http://photos.prnewswire.com/prnh/20120215/DE53620LOGO )

"We are delighted to add these high performance products to our solutions and launch them here in the UK as we did last week in the US," said David Walsh, CEO DGP Intelsius.  "Not only will this range of products benefit our customers and protect their valuable payloads, but a portion of the proceeds of each sold in the UK and throughout Europe will be donated to our chosen whale and dolphin charity partner, ORCA," Walsh said. 

The ORCA line is a high performance range of solutions that provide superior thermal protection for high value, temperature sensitive payloads.  The entire ORCA range is ATMOS™ (Analytical Thermal Modeling Software) enabled allowing quick risk assessment for the suitability of ORCA on routes around the world.

"The ORCA range also has the option of utilizing our advanced proprietary Thermocline Technology™ (TCT) that allows the ORCA solutions 30 percent extended duration in warm to extreme heat environments and greater controlled pre-conditioning.  Thermochromic labels provide visual verification of readiness for packing," Walsh said.

The partnership with the ORCA charity aligns the growing global presence of Intelsius and its commitment to environmental stewardship.  "We thank Intelsius for donating a portion of the proceeds from these products to help us," said Sally Hamilton, ORCA executive director.  Founded in 2000, ORCA is a marine conservation charity dedicated to forging links between people and the sea through the study of whales, dolphins and porpoises.

About Intelsius
Incorporated in 1998, Intelsius is a subsidiary of DGP Life Science Ltd, which is headquartered in York, United Kingdom. Intelsius serves a wide range of organizations, including government agencies, leading pharmaceutical, biopharmaceutical and clinical research industries to major laboratories. With a strong focus on developing environmentally sustainable products and procedures, the company offers solutions to ensure the integrity of customers' products and samples for better human and animal health worldwide. Intelsius has a growing global presence with manufacturing facilities, distribution hubs and local offices situated throughout the world, including North America, Europe and Asia. For more information, visit www.intelsius.com.


'/>"/>
SOURCE Intelsius
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dr. F. John Mills Joins Intelsius Board of Directors as Non-Executive Chair
2. Intelsius Forms Strategic Partnership With American Thermal Instruments to Launch Industrys First Fully Integrated Temperature-Controlled Packaging and Monitoring Solution
3. Intelsius Hires New Chief Financial Officer to Manage Continued Global Growth
4. Iomai Launches Phase 1/2 Safety Study of Dose-Sparing Patch for Use With Pandemic Influenza Vaccine
5. Keeping the Data Center Clean: ATEN Launches Industry-First KVM Switches with Antimicrobial Nanocoating to Protect Products from Bacteria Surviving on Surfaces
6. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
7. Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ
8. Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog
9. deCODE Launches Phase II Clinical Testing of DG051 for the Prevention of Heart Attack
10. Premier Micronutrient Launches Supplement for Hearing Health
11. deCODE Launches deCODE MI(TM) -- A Test for a Major Genetic Risk Factor for Early-onset Heart Attack
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... , March 24, 2017 FinancialBuzz.com ... ... leading publisher of cannabis market research, the legal cannabis market ... CAGR through 2021, despite conflicting signals from the current presidential ... out that the two biggest drivers of growth in this ...
(Date:3/24/2017)... Research and Markets has announced the addition of ... to their offering. ... IPF pipeline is very strong with a total of 97 drug candidates. ... and Sanofi are involved in the development of the IPF therapeutics. The ... Phase III stage, 15 are in Phase II stage, 12 are in ...
(Date:3/24/2017)... March 24, 2017 A ReportsnReports.com report says, ... growing rapidly as the global sales of Adcetris and Kadcyla have ... the antibody drug conjugates market is driven by large number of ... wider therapeutic window offered by ADCs. ... Browse 3 Tables and 94 Figures, 10 Major ...
Breaking Medicine Technology:
(Date:3/24/2017)... ... 24, 2017 , ... Judy Buchanan, co-owner of Serenity Natural ... Judy says, “I am passionate about sharing Reiki as a holistic, complementary therapy ... challenging time.” , A Certified Medical Reiki™ Master trained by Raven Keys Medical ...
(Date:3/24/2017)... ... March 24, 2017 , ... “End Time GPS”: a dauntless and ... “End Time GPS” is the creation of published author, Wesley Gerboth, a World ... military munitions and space-vehicle projects. Now, at age ninety-one, he shares the Wisdom God ...
(Date:3/24/2017)... ... 24, 2017 , ... “The Communion of Saints: A Pastor’s ... in congregations across the United States. “The Communion of Saints” is the ... has served congregations in seven states throughout his long career of devotion to ...
(Date:3/23/2017)... ... 2017 , ... In 2016 the World Health Organization declared the Zika virus ... Zika-related cases in the Americas within the next year. Lyme disease is one of ... skyrocketing to an estimated 329,000. Yet, Zika, Lyme and other insect borne illnesses are ...
(Date:3/23/2017)... ... March 23, 2017 , ... The physicians of KSF Orthopaedic Center PA ... Area. The new location is located at 2255 E. Mossy Oaks Rd., Suite 440, ... newest location will provide patients living in the north Houston area (The Woodlands, Conroe, ...
Breaking Medicine News(10 mins):